Clinical trial
Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus
NCT03414892
Study timeline
Study start (actual)2018-01-03Date precision: day
Registry last updated2020-01-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hyperglycaemia (Diabetic)unresolved
Type 2 Diabetes Mellitusunresolved
Interventions
Sponsors & collaborators
Yabao Pharmaceutical Grouplead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03414892 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.